China NMPA Drug Inspection - Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. - Salt-based Psoralea corylifolia

The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on April 2, 2018, detailing the results of drug supervision and sampling inspections conducted in Tianjin. These inspections, concluded by March 28, 2018, aimed to enhance drug oversight and ensure public safety regarding medication quality across production, operation, and usage stages. The announcement identified three batches of drugs that failed to meet quality standards based on the Chinese Pharmacopoeia. Anguo Changda Traditional Chinese Medicine Decoction Pieces Co., Ltd. produced substandard Amomum villosum, failing content determination for Borneol Acetate. Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. was cited for unqualified Salt-processed Psoralea corylifolia due to issues in content determination. Additionally, Dalian Quanjian Traditional Chinese Medicine Pieces Co., Ltd. produced unqualified Alum, failing an inspection for Ammonium Salt. In response, municipal market supervision and law enforcement departments were directed to promptly investigate and address the identified deficiencies. The Commission committed to continuing enhanced supervision and inspection of traditional Chinese medicine decoction pieces, alongside strengthening risk prevention and control measures to safeguard public health.